Lancer Container Lines Limited (BOM:539841)

Inozyme Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	308.47	354.18	409.9	483.37	188.43
Short-Term Investments	-	77.42	-	-	-	-
Trading Asset Securities	-	-	64.28	52.05	20.52	57.63
Cash & Short-Term Investments	385.9	385.9	418.46	461.95	503.89	246.07
Cash Growth	-7.78%	-7.78%	-9.41%	-8.32%	104.78%	177.48%
Accounts Receivable	-	747.58	1,125	939.78	553.16	307.07
Other Receivables	-	2.4	2.06	2.32	14.53	0.65
Receivables	-	749.97	1,127	942.1	567.69	307.72
Inventory	-	28.81	27.22	28.27	44.26	11.17
Prepaid Expenses	-	-	2.06	0.01	0.01	0.06
Other Current Assets	-	201.13	53.75	26.52	25.49	28.79
Total Current Assets	-	1,366	1,628	1,459	1,141	593.8
Property, Plant & Equipment	-	4,599	1,419	1,312	861.83	648.06
Long-Term Investments	-	0.1	5.1	0.1	0	0
Other Intangible Assets	-	6.59	2.66	0.83	1.07	1.79
Long-Term Deferred Charges	-	-	0.61	1.2	-	0.09
Other Long-Term Assets	-	59.94	2,564	2,491	11.56	12.03
Total Assets	-	6,032	5,619	5,264	2,016	1,256
Accounts Payable	-	352.81	408.97	403.27	417.49	455.07
Accrued Expenses	-	-	33.92	145.94	395.98	10.34
Short-Term Debt	-	-	-	-	49.99	9.5
Current Portion of Long-Term Debt	-	165.69	179.02	40.88	39	41.5
Current Portion of Leases	-	2.87	6.61	36.21	33.49	21.81
Current Income Taxes Payable	-	-	-	0.25	-	0.2
Other Current Liabilities	-	127.07	32.93	40.65	35.25	25.46
Total Current Liabilities	-	648.44	661.44	667.18	971.2	563.89
Long-Term Debt	-	494.63	936.97	2,644	159.69	170.69
Long-Term Leases	-	-	2.87	106.86	139.37	65.82
Long-Term Deferred Tax Liabilities	-	16.38	13.88	10.24	8.16	6.87
Other Long-Term Liabilities	-	-0	0.35	0.77	1.37	1.82
Total Liabilities	-	1,161	1,616	3,431	1,283	809.87
Common Stock	-	1,252	1,143	307.77	301.41	100.47
Additional Paid-In Capital	-	-	1,983	155.31	-	-
Retained Earnings	-	-	787.65	968.31	431.03	345.43
Comprehensive Income & Other	-	3,618	90.01	401.64	-	-
Shareholders' Equity	4,870	4,870	4,003	1,833	732.44	445.9
Total Liabilities & Equity	-	6,032	5,619	5,264	2,016	1,256
Total Debt	663.19	663.19	1,125	2,828	421.54	309.32
Net Cash (Debt)	-277.29	-277.29	-707	-2,366	82.35	-63.25
Net Cash Per Share	-0.79	-0.80	-3.20	-11.12	0.46	-0.35
Filing Date Shares Outstanding	256.42	240.31	228.55	184.66	180.85	180.85
Total Common Shares Outstanding	256.42	240.31	228.55	184.66	180.85	180.85
Working Capital	-	717.37	966.68	791.66	170.14	29.91
Book Value Per Share	20.27	20.27	17.52	9.93	4.05	2.47
Tangible Book Value	4,864	4,864	4,000	1,832	731.37	444.11
Tangible Book Value Per Share	20.24	20.24	17.50	9.92	4.04	2.46
Land	-	-	2.07	2.07	2.07	2.07
Buildings	-	-	191.04	191.04	231.05	231.05
Machinery	-	-	1,890	1,488	800.97	658.45
Construction In Progress	-	-	0.07	-	53	-

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.